ARCHIVES

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

This article is from The Cancer Letter archive.

Vol. 05 No. 25 | June 22, 1979

Download PDF Visit The Full Archive

Related Articles

Budget Resolution Includes Extra Money For NCI

July 2, 1982

Rumors Preceded Broder’s Move

December 22, 1994

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

NCI Signs Letters Of Intent With Latin American Countries

October 2, 2009

OCC Has Answers Ready Or Most Questions Asked

March 21, 1980

In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application

June 20, 1980